Please ensure Javascript is enabled for purposes of website accessibility

AxoGen(AXGN)

Nasdaq Capital Market (Nasdaq)

AXGN
AxoGen Stock Quote
$19.93 -$1.68 -7.8%
Price as of March 4, 2021, 9:00 p.m. EST View Interactive AXGN Charts

AxoGen Inc. is a regenerative medicine company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration.

Interactive Chart


News & Analysis: AxoGen

All

Market Moves

Earnings

Key Data Points

Primary metrics and data points about AxoGen.
Market Cap: $880M
Current Price: $19.93
Day's Range: $19.80 - $21.95
52wk Range: $7.16 - $22.89
Volume: 570,985
Avg Vol 269,764

Company Rating

What our community thinks about AxoGen
CAPS Rating 2 out of 5
 
15 Outperform
2 Underperform
CAPS All Stars
 
6 Outperform
1 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company
Karen Zaderej, CEO

Karen Zaderej, CEO

76% Approve

Based on 5 Ratings

Powered by Glassdoor

Business Summary

AxoGen Inc. is a regenerative medicine company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration.

Sector: Health Care
Industry: Healthcare Equipment and Supplies

13631 Progress Boulevard Suite 400
Alachua, FL 32615
United States
www.axogeninc.com